Erdafitinib for the Treatment of Patients With Castration-Resistant Prostate Cancer

Clinical trial NCT04754425 · TERMINATED

Trial details

NCT number: NCT04754425
Sponsor: M.D. Anderson Cancer Center
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Castration-Resistant Prostate Carcinoma Castration-Resistant Prostate Carcinoma Refractory to Second-Generation Androgen Receptor Axis-Targeted Agents Metastatic Malignant Neoplasm in the Bone Metastatic Prostate Adenocarcinoma Metastatic Prostate Small Cell Neuroendocrine Carcinoma Stage IV Prostate Cancer AJCC v8 Stage IVA Prostate Cancer AJCC v8 Stage IVB Prostate Cancer AJCC v8

Start date: 2021-07-15
Primary completion: 2026-02-02
Enrollment: 11

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.